ZIPRASIDONE Side Effects

5157059-6 | Blood Cholesterol Abnormal, Diabetes Mellitus, Glycosuria, Hypertension, Myocardial Infarction, Obesity
on Mar 06, 2006 Male patient from UNITED STATES , 51 years of age, weighting 220.0 lb, was treated with Ziprasidone (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol abnormal, diabetes mellitus, glycosuria, hypertension, myocardial infarction, obesity (What is obesity?). Ziprasidone dosage: . During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), MELLARIL (View Mellaril Review and Mellaril Label ), DIVALPROEX SODIUM (View Divalproex Sodium Review and Divalproex Sodium Label ), COGENTIN /UNK/ (View Cogentin /unk/ Review and Cogentin /unk/ Label ), ATIVAN (View Ativan Review and Ativan Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZYPREXA (2.5 Mg, Unk) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

5153757-9 | Biliary Tract Disorder, Blood Cholesterol Increased, Blood Triglycerides Increased, Hypertension, Ketonuria, Pancreatitis
Patient was taking Ziprasidone (View Usage). Patient had the following side effects: biliary tract disorder, blood cholesterol increased, blood triglycerides increased, hypertension, ketonuria, pancreatitis on May 09, 2006 from UNITED STATES Additional patient health information: Female patient , 44 years of age, weighting 198.0 lb, . Ziprasidone dosage: . During the same period patient was treated with BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ), FLUOXETINE /N/A/ (View Fluoxetine /n/a/ Review and Fluoxetine /n/a/ Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), NEFAZODONE HCL (View Nefazodone Hcl Review and Nefazodone Hcl Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), ZYPREXA (10 Mg, Unk) (View Zyprexa Review and Zyprexa Label ). Patient was hospitalized.

5153734-8 | Blood Cholesterol Abnormal, Blood Triglycerides Increased, Diabetes Mellitus, Glucose Tolerance Impaired, Hypertension, Lactic Acidosis, Obesity
Adverse event was reported on May 02, 2006 by a Male patient taking Ziprasidone (View Usage) (Dosage: ) . Location: UNITED STATES , 43 years of age, weighting 309.9 lb, After Ziprasidone was administered, patient had the following side effects: blood cholesterol abnormal, blood triglycerides increased, diabetes mellitus, glucose tolerance impaired, hypertension, lactic acidosis, obesity (What is obesity?). During the same period patient was treated with ZYPREXA (20 Mg, Unk) (View Zyprexa Review and Zyprexa Label ).

4734762-0 | Swelling
on Aug 03, 2005 Male patient from UNITED STATES , 47 years of age, weighting 188.5 lb, was treated with Ziprasidone (View Usage). Patient experienced the following unwanted or unexpected effects: swelling. Ziprasidone dosage: .


4698946-2 | Body Temperature Increased, Convulsion, Neuroleptic Malignant Syndrome
on Jun 22, 2005 Female patient from , 34 years of age, weighting 114.6 lb, was diagnosed with agitation, sedation and was treated with Ziprasidone (View Usage). Patient had the following side effects: body temperature increased, convulsion, neuroleptic malignant syndrome. Ziprasidone dosage: 20 Mg Im Prn. During the same period patient was treated with RISPERIDONE (1 Mg Q Hs) (View Risperidone Review and Risperidone Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), TYLENOL (View Tylenol Review and Tylenol Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

4681886-2 | Agitation, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Grand Mal Convulsion, Hyponatraemia, Polydipsia
Patient was taking Ziprasidone (View Usage). After Ziprasidone was administered, patient had the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, grand mal convulsion, hyponatraemia, polydipsia on May 20, 2005 from Additional patient health information: Male patient , 31 years of age, weighting 121.3 lb, was diagnosed with ill-defined disorder and. Ziprasidone dosage: 120 Mg (60 Mg, 2 In 1 D), Oral. Patient was hospitalized.

4681886-2 | Agitation, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Grand Mal Convulsion, Hyponatraemia, Polydipsia
Adverse event was reported on May 20, 2005 by a Male patient taking Ziprasidone (View Usage) (Dosage: 120 Mg (60 Mg, 2 In 1 D), Oral) was diagnosed with ill-defined disorder and. Location: TURKEY , 31 years of age, weighting 121.3 lb, Patient experienced the following unwanted or unexpected effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, grand mal convulsion, hyponatraemia, polydipsia. Patient was hospitalized.

4673510-X | Agitation, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Grand Mal Convulsion, Hyponatraemia, Polydipsia
on May 09, 2005 Male patient from , 32 years of age, weighting 121.3 lb, was diagnosed with ill-defined disorder and was treated with Ziprasidone (View Usage). Patient had the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, grand mal convulsion, hyponatraemia, polydipsia. Ziprasidone dosage: 120 Mg (60 Mg, 2 In 1 D), Oral. Patient was hospitalized.

4669469-1 | Dizziness, Fall, Gait Disturbance, Hallucination, Auditory, Headache, Hypotension, Loss Of Consciousness, Syncope
on May 06, 2005 Male patient from , 37 years of age, weighting 156.5 lb, was diagnosed with schizophrenia and was treated with Ziprasidone (View Usage). After Ziprasidone was administered, patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), gait disturbance, hallucination, auditory, headache (What is headache?), hypotension, loss of consciousness, syncope. Ziprasidone dosage: 40 Mg (20 Mg, 2 In 1 D), Oral. During the same period patient was treated with FLUNITRAZEPAM (FLUNITRAZEPAM) (View Flunitrazepam (flunitrazepam) Review and Flunitrazepam (flunitrazepam) Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ). Patient was hospitalized.

4664962-X | Delirium, Hypotension, Pyrexia
Patient was taking Ziprasidone (View Usage). Patient experienced the following unwanted or unexpected effects: delirium, hypotension, pyrexia on May 17, 2005 from Additional patient health information: Male patient , 47 years of age, weighting 267.0 lb, . Ziprasidone dosage: .

4664961-8 | Blood Creatine Phosphokinase Increased, Delirium, Pyrexia
Adverse event was reported on May 17, 2005 by a Male patient taking Ziprasidone (View Usage) (Dosage: ) . Location: , 47 years of age, weighting 267.0 lb, Patient had the following side effects: blood creatine phosphokinase increased, delirium, pyrexia.

4635235-6 | Blood Cholesterol Increased, Blood Triglycerides Increased, Body Mass Index Increased, Circulatory Collapse, Diabetes Mellitus Insulin-dependent, Diabetes Mellitus Non-insulin-dependent, Difficulty In Walking, Hypertension, Low Density Lipoprotein Increased
on Apr 08, 2005 Male patient from , 27 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Ziprasidone (View Usage). After Ziprasidone was administered, patient had the following side effects: blood cholesterol increased, blood triglycerides increased, body mass index increased, circulatory collapse, diabetes mellitus insulin-dependent, diabetes mellitus non-insulin-dependent, difficulty in walking, hypertension, low density lipoprotein increased. Ziprasidone dosage: . During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), CLOZAPINE (400 Mg/d) (View Clozapine Review and Clozapine Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), RISPERIDONE (3 Mg, Bid) (View Risperidone Review and Risperidone Label ), QUETIAPINE (800 Mg/d) (View Quetiapine Review and Quetiapine Label ), HALOPERIDOL (5 Mg/d) (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

4634362-7 | Feeling Abnormal, Impulsive Behaviour, Insomnia, Overdose
on Sep 07, 2004 Female patient from , 45 years of age, was diagnosed with schizophrenia and was treated with Ziprasidone (View Usage). Patient experienced the following unwanted or unexpected effects: feeling abnormal, impulsive behaviour, insomnia, overdose. Ziprasidone dosage: 80 Mg (40 Mg, 2 In 1 D), Oral. During the same period patient was treated with ZOPICLONE (ZOPICLONE) (View Zopiclone (zopiclone) Review and Zopiclone (zopiclone) Label ). Patient was hospitalized.

4559971-5 | Hyperhidrosis, Hypotension
Patient was taking Ziprasidone (View Usage). Patient had the following side effects: hyperhidrosis, hypotension on Jan 20, 2005 from Additional patient health information: Male patient , 29 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and. Ziprasidone dosage: 80 Mg Po Daily [one Dose].

4551901-5 | Neuroleptic Malignant Syndrome
Adverse event was reported on Dec 27, 2004 by a Male patient taking Ziprasidone (View Usage) (Dosage: 160 Mg (80 Mg, 2 In 1 D),oral) was diagnosed with schizophrenia and. Location: , 29 years of age, weighting 168.7 lb, After Ziprasidone was administered, patient had the following side effects: neuroleptic malignant syndrome. During the same period patient was treated with CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), TRIHEXYPHENIDYL HYDROCHORIDE (View Trihexyphenidyl Hydrochoride Review and Trihexyphenidyl Hydrochoride Label ), PHENOLPHTHALEIN (PHENOLPHTHALEIN) (View Phenolphthalein (phenolphthalein) Review and Phenolphthalein (phenolphthalein) Label ), RISPERDAL (View Risperdal Review and Risperdal Label ).